Efficacy and safety of pyrotinib and radiotherapy vs. pyrotinib-based therapy in patients with HER2(+) breast cancer with brain metastasis: a retrospective cohort study

BACKGROUND: At present, local therapy, such as surgery and radiotherapy, is the mainstay treatment for brain metastasis and anti-human epidermal growth factor receptor type 2 (HER2)-targeted therapy has been shown to be efficacious for HER2(+) breast cancer (BC) patients with brain metastasis. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jiaxin, Zhang, Huiqiang, Zhou, Jinmei, Wu, Zisheng, Wu, Xuexue, Zhang, Shaohua, Jiang, Zefei, Wang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761172/
https://www.ncbi.nlm.nih.gov/pubmed/36544628
http://dx.doi.org/10.21037/atm-22-5352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761172/
https://www.ncbi.nlm.nih.gov/pubmed/36544628
http://dx.doi.org/10.21037/atm-22-5352

Ejemplares similares